As a qualified treatment practitioner for hair + scalp problems, my responsibilities to you is to identify + establish the cause/s of your condition, AND suggest the most appropriate treatment option/s for you*.
Whilst there is a standard treatment regime for genetic balding in males – the cause/s of female scalp hair loss may be the result of multi-faceted nutritional-metabolic-hormonal or autoimmune disturbance.
This FIRST requires a thorough history evaluation of the Client, with specific ‘evidence-gathering’ pathology testing to establish underlying cause/s to the presenting problem.
Appropriate treatment/s may then be suggested to aid in correcting the underlying disturbance and provide optimal outcomes for the Client.
Following initial consultation and pathology assessment, this is the usual treatment approach I would tend to suggest for my FEMALE clients:
There are innumerable topical treatments being offered online,
in pharmacies; hair salons – even in supermarkets.
Activance’s appeal is there are no known side effects from its use; safe for all ages and both sexes – including during pregnancy and breast-feeding. Its solid anti-inflammatory effects allow it to be multi- purpose: acne, burns (including sun over-exposure) and stinging bites.
Additionally, Minoxidil is therapeutically effective in only 45% of users (Chan: 2019) as it needs to be converted to Minoxidil sulphate to be activated. According to Chan, 55% of the population lack the conversion enzyme or produce an incompetent enzyme to effect conversion.
‘Next generation’ Minoxidil are pre-converted ‘hybrid’ medication-nutrient-phyto (plant-based) combinations to enhance skin penetration, inhibit hormone-induced follicle regression, and be anti- inflammatory to the skin environment.
NEW + exclusive to AP Trichology
IL-6 is a key modulator of hair loss and inhibiting its over-expression in the hair follicle has been the subject of much research. When the androgenic scalp hair thinning process is activated, IL-6 gene expression is up-regulated, so both IL-6 concentration and activity is increased. Equol ’Plus’ binds and inactivates DHT, which in turn blocks IL-6 formation. (1) Interleukin-6: an endogenous chemical active in inflammation.
DMSO is a non-damaging skin absorption enhancer for topical medication (Equol) as well as scalp anti-inflammatory and analgesic agent. Unlike Retinoic acid or Cortisone, DMSO does NOT adversely alter skin (epidermis) structure. DMSO is available in strengths of 0.1%, 0.3% and 1.0% – (available soon and exclusively from Anthony Pearce Trichology)